Inactive Instrument

Calendar Rezolute Inc Other OTC

Equities

Chart calendar Rezolute Inc

2c26195e376.SoWUlH6M_PM5jYqG27DB8RfM29W6aRoDabhtxfByteI.Ae2t1k_WnZVpwujwneWswkGn9qP_M3Y6HNoF8aYC0Lgc98fwSLq3nnjv_Q~d8a498004a91e5df06270772d6a5f2a1

Upcoming events on Rezolute Inc

11/09/2024 Q4 2024 Earnings Release (Projected)
06/11/2024 Q1 2025 Earnings Release (Projected)
04/02/2025 Q2 2025 Earnings Release (Projected)

Past events on Rezolute Inc

13/05/2024 Q3 2024 Earnings Release (Projected)
04/05/2024 18:15 Pediatric Endocrine Society Meeting - Abstract No : 6790
13/02/2024 21:05 Q2 2024 Earnings Release
27/11/2023 19:30 BTIG Ophthalmology Day
13/11/2023 21:05 Q1 2024 Earnings Release
26/09/2023 19:10 Cantor Global Healthcare Conference
14/09/2023 21:05 Q4 2023 Earnings Release
12/09/2023 19:00 H.C. Wainwright Global Investment Conference
27/06/2023 21:30 RZ358 Phase3 Update Call
25/05/2023 23:00 Annual General Meeting
11/05/2023 21:05 Q3 2023 Earnings Release
22/03/2023 20:30 Investor Meeting - Key Opinion Leader
10/02/2023 21:05 Q2 2023 Earnings Release
17/11/2022 16:25 Jefferies London Healthcare Conference
09/11/2022 21:05 Q1 2023 Earnings Release
03/11/2022 17:47 Retina Society Scientific Meeting
15/09/2022 21:05 FY 2022 Earnings Release
15/09/2022 13:55 European Society for Paediatric Endocrinology Conference - Abstract Code FC3.2
16/06/2022 23:00 Annual General Meeting
12/05/2022 21:05 Q3 2022 Earnings Release

Annual results

Fiscal PeriodJuni 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-25,9
-31,3
17.11%
0,00
0,00
-
-22,9
-22,5
-1.68%
-41,8
-45,1
7.27%
-56,0
-60,0
6.65%

-65,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-30,4
-35,8
14.96%
0,00
0,00
-
-20,9
-22,1
5.26%
-41,1
-46,7
12.08%
-51,8
-58,0
10.74%

-61,8

Net income
Million USD
Released
Forecast
Spread
-30,4
-35,8
14.96%
-20,3
-21,8
6.73%
-20,9
-21,6
3.15%
-41,1
-46,7
12.08%
-51,8
-57,8
10.46%

-61,0

EPS
USD
Released
Forecast
Spread
-18,5
-15,0
-23.33%
-3,54
-4,00
11.5%
-2,72
-2,82
3.63%
-2,26
-2,48
8.99%
-1,01
-1,22
17.35%

-1,12

Announcement Date10/09/1913/10/2015/09/2115/09/2214/09/23-

Quarterly results

Fiscal PeriodJuni 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-12,1
-8,67
-40.21%
-10,8
-15,5
30.66%
-11,3
-14,6
22.58%
-10,2
-12,2
16.06%
-14,4
-15,5
7.41%
-17,1
-15,7
-8.84%
-14,2
-18,2
21.82%
-15,9
-16,5
3.52%
-15,2
-18,1
15.94%

-16,8


-17,2


-18,0


-19,2


-20,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-12,6
-8,98
-40.31%
-11,2
-16,2
30.67%
-9,42
-15,1
37.5%
-9,83
-12,4
20.86%
-13,6
-13,5
-0.27%
-15,7
-15,6
-0.51%
-12,7
-18,5
31.21%
-14,5
-16,4
11.25%
-13,9
-16,7
16.57%

-16,2


-16,1


-18,0


-19,2


-20,4

Net income
Million USD
Released
Forecast
Spread
-12,6
-8,93
-41%
-11,2
-15,9
29.62%
-9,42
-15,1
37.5%
-9,83
-12,4
20.86%
-13,6
-13,5
-0.27%
-15,7
-15,6
-0.51%
-12,7
-18,5
31.21%
-14,5
-13,5
-7.86%
-13,9
-16,9
17.58%

-16,2


-16,1


-18,0


-19,2


-20,4

EPS
USD
Released
Forecast
Spread
-0,80
-0,69
-16.28%
-0,65
-0,91
28.26%
-0,30
-0,56
45.95%
-0,19
-0,31
39.36%
-0,26
-0,32
18.24%
-0,30
-0,30
0%
-0,25
-0,36
29.78%
-0,28
-0,28
0.88%
-0,27
-0,29
6.9%

-0,30


-0,28


-0,32


-0,32


-0,29

Announcement Date09/02/2212/05/2215/09/2209/11/2210/02/2311/05/2314/09/2313/11/2313/02/24-----